# Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/acquired-resistance-to-osimertinib-in-patients-with-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuxin Mu,Xuezhi Hao,Puyuan Xing,Xingsheng Hu,Yan Wang,Li Teng,Jinyao Zhang,Ziyi Xu,Junling Li |
| Citations | 67 |
| DOI | 10.1007/s00432-020-03239-1 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00432-020-03239-1.pdf |
| OpenAlex ID | https://openalex.org/W3021120472 |
| PMID | 32385709 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Xingsheng Hu](https://scholariq.org/researchers/xingsheng-hu/)
- [Xuezhi Hao](https://scholariq.org/researchers/xuezhi-hao/)
- [Yan Wang](https://scholariq.org/researchers/yan-wang/)
- [Puyuan Xing](https://scholariq.org/researchers/puyuan-xing/)
- [Junling Li](https://scholariq.org/researchers/junling-li/)

## Paper journal

- [Journal of Cancer Research and Clinical Oncology](https://scholariq.org/journals/journal-of-cancer-research-and-clinical-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Fibroblast Growth Factor Research](https://scholariq.org/topics/fibroblast-growth-factor-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.